17. Ann Oncol. 2018 May 1;29(5):1096-1098. doi: 10.1093/annonc/mdy115.Should decisions on adding adjuvant chemotherapy in early-stage ER-positivebreast cancer be based on gene expression testing or clinicopathologic factors orboth?Geffen DB(1).Author information: (1)Department of Oncology, Soroka University Medical Center, Faculty of HealthSciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.DOI: 10.1093/annonc/mdy115 PMID: 29635411 